Epilepsy medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:
*** The initial dose is 2-3 mg/kg per day divided into at least two time.  
*** The initial dose is 2-3 mg/kg per day divided into at least two time.  
*** The maximum dosing is 10 mg/kg three-times-daily.  
*** The maximum dosing is 10 mg/kg three-times-daily.  
*** The most common side effects of this drug are GI disturbance, rash, hyponatremia and fluid retention.<ref name="pmid18981374">{{cite journal |vauthors=Hirsch LJ, Arif H, Nahm EA, Buchsbaum R, Resor SR, Bazil CW |title=Cross-sensitivity of skin rashes with antiepileptic drug use |journal=Neurology |volume=71 |issue=19 |pages=1527–34 |date=November 2008 |pmid=18981374 |doi=10.1212/01.wnl.0000334295.50403.4c |url=}}</ref> (1,5)
*** The most common side effects of this drug are GI disturbance, rash, hyponatremia and fluid retention.<ref name="pmid18981374">{{cite journal |vauthors=Hirsch LJ, Arif H, Nahm EA, Buchsbaum R, Resor SR, Bazil CW |title=Cross-sensitivity of skin rashes with antiepileptic drug use |journal=Neurology |volume=71 |issue=19 |pages=1527–34 |date=November 2008 |pmid=18981374 |doi=10.1212/01.wnl.0000334295.50403.4c |url=}}</ref> (1,5)
** Eslicarbazepin
** Eslicarbazepin
** Lacosamide
** Lacosamide

Revision as of 00:01, 5 December 2018

Epilepsy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Epilepsy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

EEG

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Epilepsy medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Epilepsy medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Epilepsy medical therapy

CDC on Epilepsy medical therapy

Epilepsy medical therapy in the news

Blogs on Epilepsy medical therapy

Directions to Hospitals Treating Epilepsy

Risk calculators and risk factors for Epilepsy medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

overview

Medical Therapy

Pharmacologic medical therapies for epilepsy is antiseizure drugs such as:

  • Drugs that affect voltage-dependent Na+ channels
    • Carbamazepin:
      • The initial dose is 2-3 mg/kg per day divided into at least two time.
      • The maximum dosing is 10 mg/kg three-times-daily.
      • The most common side effects of this drug are GI disturbance, rash, hyponatremia and fluid retention.[1] (1,5)
    • Eslicarbazepin
    • Lacosamide
    • Oxcarbazepine
    • Phenytoin
    • Rufinamide
  • Drugs that affect Ca currents
    • Ethosuximide
  • Drugs that affect GABA activity
    • Benzodiazepines
    • Phenobarbital
    • Tiagabine
    • Vigabatrin
  • Drugs that affect glutamate receptor
    • Perampanel
  • Drugs with multiple mechanisms of action
    • Felbamate
    • Topiramate
    • Valporate
  • Drugs with other mechanisms of action
    • Brivaracetam
    • Gabapentin
    • Levetiracetam
    • Pregabalin

References

  1. Hirsch LJ, Arif H, Nahm EA, Buchsbaum R, Resor SR, Bazil CW (November 2008). "Cross-sensitivity of skin rashes with antiepileptic drug use". Neurology. 71 (19): 1527–34. doi:10.1212/01.wnl.0000334295.50403.4c. PMID 18981374.

Template:WH Template:WS